PL2903624T3 - Pożywka kondycjonowana przez łożyskowe mezenchymalne komórki macierzyste z łożyska kobiety dotkniętej stanem przedrzucawkowym do stosowania w leczeniu nowotworu - Google Patents

Pożywka kondycjonowana przez łożyskowe mezenchymalne komórki macierzyste z łożyska kobiety dotkniętej stanem przedrzucawkowym do stosowania w leczeniu nowotworu

Info

Publication number: PL2903624T3
Authority: PL; Poland
Prior art keywords: tumour; treatment; stem cell; mesenchymal stem; conditioned medium
Prior art date: 2012-10-02

Application number

PL13792477T

Other languages

English (en)

Inventor

Alessandro Rolfo

Tullia Todros

Original Assignee

Corion Biotech S.R.L.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-10-02

Filing date

2013-10-02

Publication date

2019-07-31

2013-10-02 Application filed by Corion Biotech S.R.L. filed Critical Corion Biotech S.R.L.

2019-07-31 Publication of PL2903624T3 publication Critical patent/PL2903624T3/pl

Links

206010028980 Neoplasm Diseases 0.000 title 1
239000003636 conditioned culture medium Substances 0.000 title 1
210000002901 mesenchymal stem cell Anatomy 0.000 title 1
230000003169 placental effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2033—IL-5
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2046—IL-7
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2053—IL-8
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2086—IL-13 to IL-16
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/10—Protein-tyrosine kinases (2.7.10)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/27—Endoribonucleases producing 3'-phosphomonoesters (3.1.27)
- C12Y301/27008—Ribonuclease V (3.1.27.8)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Cell Biology (AREA)
Developmental Biology & Embryology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Virology (AREA)
Oncology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL13792477T 2012-10-02 2013-10-02 Pożywka kondycjonowana przez łożyskowe mezenchymalne komórki macierzyste z łożyska kobiety dotkniętej stanem przedrzucawkowym do stosowania w leczeniu nowotworu PL2903624T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IT000859A ITTO20120859A1 (it)	2012-10-02	2012-10-02	Nuova applicazione terapeutica di un mezzo condizionato da cellule staminali mesenchimali placentari
PCT/IB2013/059064 WO2014054004A1 (en)	2012-10-02	2013-10-02	Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour
EP13792477.5A EP2903624B1 (en)	2012-10-02	2013-10-02	Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour

Publications (1)

Publication Number	Publication Date
PL2903624T3 true PL2903624T3 (pl)	2019-07-31

Family

ID=47278467

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13792477T PL2903624T3 (pl)	2012-10-02	2013-10-02	Pożywka kondycjonowana przez łożyskowe mezenchymalne komórki macierzyste z łożyska kobiety dotkniętej stanem przedrzucawkowym do stosowania w leczeniu nowotworu

Country Status (11)

Country	Link
US (1)	US9943548B2 (pl)
EP (1)	EP2903624B1 (pl)
JP (1)	JP6306025B2 (pl)
CN (2)	CN108939051B (pl)
CA (1)	CA2886946C (pl)
DK (1)	DK2903624T3 (pl)
ES (1)	ES2720232T3 (pl)
IT (1)	ITTO20120859A1 (pl)
PL (1)	PL2903624T3 (pl)
TR (1)	TR201905632T4 (pl)
WO (1)	WO2014054004A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20170226472A1 (en) *	2014-08-04	2017-08-10	Universidad De Granada	Culture medium and method for enriching and maintaining cancer stem cells (cscs) using said medium
RU2644650C2 (ru) *	2014-12-01	2018-02-13	Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии"	Материал стволовых клеток и способ его получения
US11291689B2 (en)	2015-06-03	2022-04-05	Aelan Cell Technologies, Inc.	Methods and devices for the production and delivery of beneficial factors from adipose-derived stem cells
WO2016196774A1 (en) *	2015-06-03	2016-12-08	Aelan Cell Technologies, Inc.	Methods and devices for the production and delivery of beneficial factors from stem cells
RU2708329C2 (ru) *	2016-05-31	2019-12-05	Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии"	Материал стволовых клеток, композиции и способы применения
EP4600348A3 (en) *	2016-08-26	2025-12-10	Restem Llc	Composition and methods of using umbilical cord lining stem cells
JP2019214514A (ja) *	2016-10-06	2019-12-19	Ａｏｆ株式会社	抗体産生力を上げる培養上清製剤
US12053493B2 (en)	2016-11-03	2024-08-06	Exostem Biotec Ltd.	Mesenchymal stem cells populations, their products, and use thereof
KR101865040B1 (ko) *	2017-01-05	2018-06-11	가톨릭대학교 산학협력단	면역조절인자의 생성능이 강화된 중간엽 줄기세포의 용도
EP3823639A4 (en) *	2018-07-18	2022-07-20	Exostem Biotec Ltd.	IMMUNOTHERAPY BASED ON EXOSOMES AND MSC
US10881693B2 (en)	2019-04-09	2021-01-05	Combangio, Inc.	Processes for making and using a mesenchymal stem cell derived secretome
CN110025769A (zh) *	2019-05-14	2019-07-19	美亚宜彬生物科技(北京)有限公司	干细胞和细胞因子的组合及其在改善精子活力的用途
CN110904031A (zh) *	2019-12-31	2020-03-24	福建省银丰干细胞工程有限公司	一种从人胎盘底蜕膜组织中分离母体来源间充质干细胞的方法
WO2021207282A2 (en)	2020-04-07	2021-10-14	Combangio, Inc.	Lyophilized mesenchymal stem cell derived secretome and uses thereof
CN112315979A (zh) *	2020-08-04	2021-02-05	源铭(上海)生物技术有限公司	药物组合物及其制备方法和应用
CN114878837A (zh) *	2022-05-31	2022-08-09	国家卫生健康委科学技术研究所	与妊娠期高血压疾病诊断相关的血清预测标志物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2530732C (en) *	2003-06-27	2015-03-31	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
US20070087986A1 (en) *	2004-01-26	2007-04-19	Brett Premack	Compositions and methods for enhancing immunity by chemoattractant adjuvants
WO2006069449A1 (en) *	2004-12-29	2006-07-06	The University Of British Columbia	Chemokine receptor-independent immunomodulatory and anti-proliferative activity
US20060257359A1 (en) *	2005-02-28	2006-11-16	Cedric Francois	Modifying macrophage phenotype for treatment of disease
US7993918B2 (en) *	2006-08-04	2011-08-09	Anthrogenesis Corporation	Tumor suppression using placental stem cells
KR20110050688A (ko) *	2008-08-22	2011-05-16	안트로제네시스 코포레이션	태반 세포 집단을 이용한 골 결함의 치료 방법 및 골 결함 치료 조성물
ITTO20111183A1 (it)	2011-12-21	2013-06-22	Univ Degli Studi Torino	Mezzo condizionato ottenuto da cellule staminali mesenchimali placentari e suo uso nel trattamento terapeutico della preeclampsia

2012
- 2012-10-02 IT IT000859A patent/ITTO20120859A1/it unknown
2013
- 2013-10-02 DK DK13792477.5T patent/DK2903624T3/en active
- 2013-10-02 PL PL13792477T patent/PL2903624T3/pl unknown
- 2013-10-02 CN CN201810895444.4A patent/CN108939051B/zh active Active
- 2013-10-02 TR TR2019/05632T patent/TR201905632T4/tr unknown
- 2013-10-02 US US14/432,722 patent/US9943548B2/en active Active
- 2013-10-02 EP EP13792477.5A patent/EP2903624B1/en active Active
- 2013-10-02 CN CN201380062876.2A patent/CN104822385B/zh active Active
- 2013-10-02 JP JP2015535152A patent/JP6306025B2/ja active Active
- 2013-10-02 WO PCT/IB2013/059064 patent/WO2014054004A1/en not_active Ceased
- 2013-10-02 CA CA2886946A patent/CA2886946C/en active Active
- 2013-10-02 ES ES13792477T patent/ES2720232T3/es active Active

Also Published As

Publication number	Publication date
ES2720232T3 (es)	2019-07-18
WO2014054004A9 (en)	2015-06-11
JP2015532099A (ja)	2015-11-09
JP6306025B2 (ja)	2018-04-04
DK2903624T3 (en)	2019-04-29
US9943548B2 (en)	2018-04-17
CA2886946C (en)	2021-06-01
EP2903624A1 (en)	2015-08-12
CN108939051A (zh)	2018-12-07
CA2886946A1 (en)	2014-04-10
EP2903624B1 (en)	2019-01-16
CN108939051B (zh)	2022-04-15
TR201905632T4 (tr)	2019-05-21
ITTO20120859A1 (it)	2014-04-03
CN104822385A (zh)	2015-08-05
WO2014054004A1 (en)	2014-04-10
CN104822385B (zh)	2019-10-01
US20150250823A1 (en)	2015-09-10

Publication	Publication Date	Title
PL2903624T3 (pl)	2019-07-31	Pożywka kondycjonowana przez łożyskowe mezenchymalne komórki macierzyste z łożyska kobiety dotkniętej stanem przedrzucawkowym do stosowania w leczeniu nowotworu
PT2793929T (pt)	2016-12-13	Meio condicionado obtido a partir de células estaminais mesenquimais da placenta e utilização do mesmo no tratamento terapêutico da pré-eclâmpsia
GB201115711D0 (en)	2011-10-26	Phyto-cannabinoids for use in the treatment of cancer
ZA201507790B (en)	2016-12-21	Enhanced adoptive cell therapy
PL2836511T3 (pl)	2018-06-29	Polipeptyd przydatny w adoptywnej terapii komórkowej
SG11201404608WA (en)	2014-09-26	Mesenchymal stem cells conditioned medium and methods of generating and using the same
IL238400A (en)	2017-07-31	Triazulophyrazines as brd4 inhibitors for use in cancer treatment
IL235709A0 (en)	2015-01-29	A process for isolation/purification of cells and methods for its use
IL230698A0 (en)	2014-03-31	Use of preparations containing crizotinib to treat cancer
SI2780332T1 (sl)	2016-06-30	Morfolinilbenzotriazini za uporabo pri terapiji raka
SG11201502317VA (en)	2015-05-28	Telomerase inhibitors for use in therapy
ZA201500547B (en)	2017-09-27	Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases
IL235127A (en)	2017-12-31	Hpn-100 for use in the treatment of nitrogen-related diseases
PT2831110T (pt)	2018-09-28	Terapia anti-emp2 reduz as células-tronco do cancro
IL238453A0 (en)	2015-06-30	Trans-clomiphene for use in cancer treatment
PT2872176T (pt)	2017-06-21	Carboranilporpirinas para utilização no tratamento de cancro
ZA201307857B (en)	2015-11-25	Culture medium for human mesenclymal stem cells
EP2823038A4 (en)	2015-08-19	PLACENTAL STEM CELLS, METHODS OF ISOLATING THESE CELLS AND USE THEREOF
SG196714A1 (en)	2014-02-13	Cancer stem cell inhibition
GB201223371D0 (en)	2013-02-06	Novel mucinase for use in therapy or prophylaxis
IL233166A0 (en)	2014-07-31	A programmable cell model for defining cancer treatments
AU2012900259A0 (en)	2012-02-09	Agents for use in cancer therapy
GB201314623D0 (en)	2013-10-02	Novel mucinase for use in therapy or prophylaxis
GB201215510D0 (en)	2012-10-17	Therapeutic cell lines
AU2012904719A0 (en)	2012-11-08	Stem cell line and use thereof